[go: up one dir, main page]

WO2002049661A1 - Preventievs/remedies for diabetes and functional foods containing the same - Google Patents

Preventievs/remedies for diabetes and functional foods containing the same Download PDF

Info

Publication number
WO2002049661A1
WO2002049661A1 PCT/JP2001/011090 JP0111090W WO0249661A1 WO 2002049661 A1 WO2002049661 A1 WO 2002049661A1 JP 0111090 W JP0111090 W JP 0111090W WO 0249661 A1 WO0249661 A1 WO 0249661A1
Authority
WO
WIPO (PCT)
Prior art keywords
diabetes
medium
preventive
cultivation
ameliorating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2001/011090
Other languages
French (fr)
Japanese (ja)
Inventor
Kuniaki Obara
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Publication of WO2002049661A1 publication Critical patent/WO2002049661A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/07Basidiomycota, e.g. Cryptococcus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L31/00Edible extracts or preparations of fungi; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates

Definitions

  • the present invention relates to a diabetes preventive and ameliorating agent and a functional food having a diabetes preventive and ameliorating effect, and more particularly to a functional food obtained from a fruit body of a mushroom belonging to the family Climacodontaceae, such as Bunakaritake (Mycoleptodonoides aitchisonii).
  • the present invention relates to a diabetes preventive or ameliorating agent having an effect of suppressing an increase in blood glucose level and an effect of improving glucose tolerance against type 1 and type 2 diabetes, and a functional food having a diabetes preventing or ameliorating effect including such a diabetes preventing or ameliorating agent.
  • beech agaric grows on fallen beech trees and dead trees in late autumn, and umbrellas are 3 to 10 cm in diameter, semicircular white, and later. Tint yellow, back white Needle-like, later yellowish on the surface as well as the surface, the meat is white, soft and water-absorbing, and is known to have a unique aroma.As a mushroom prized as mountain meat by mountain villagers Is also known.
  • Nagano Prefectural Forest Research Report No. 3 pages 32 to 37 (1989) and Fukushima Prefectural Forest Research Report No.
  • a functional food having
  • the present inventors have previously conducted an inoculation step of inoculating a seed medium of B. agaricus inoculated on a medium supplemented with a specific nutrient source, and culturing the medium inoculated with a seed of B. agaricus, and forming a fungal bed in which the mycelia grew on the medium.
  • the present inventors have been conducting various studies on the pharmacological action of the fruit body of B. aeruginosa, which has been available stably for the whole year, and found that the body of B. aeruginosa has a blood sugar level-inhibiting action and a glucose tolerance improving action. The inventors have found that the components shown are present, and have completed the present invention. Disclosure of the invention
  • FIG. 1 is a diagram for explaining a method of cultivating a fungus bed of Bunahari yuga, which forms fruiting bodies using a translucent cultivation container.
  • the fungal bed cultivation refers to a method of inoculating a seed material into a material composed of a water retaining body and a nutrient source without using a log, and cultivating in a controlled environment of temperature, humidity, illuminance, and the like.
  • a water retaining body a culture source for cultivation containing a nutrient source including at least one of dried okara and beer lees, and a sterilization step of sterilizing a medium mixed with water
  • An inoculation step in which a sterilized medium is inoculated with a fungus inoculated with a fungus, a preculture step in which the medium inoculated with a fungus inoculated with a fungus is obtained, and a culture bed in which hypha grows in the medium is obtained.
  • a medium cultivation step for obtaining a P is
  • agaricus primordium that is not exposed to a physical space capable of growing the fruiting body; and a cultivation primordial primrose that is not exposed to the physical space capable of growing the fruiting body.
  • An artificial cultivation comprising a post-culturing step of cultivating a primordium that is exposed to a physical space in which the fungus can grow into a fruiting body and obtaining a fruiting body of the fungus can be specifically exemplified.
  • the physical space that can grow into a fruiting body refers to a space in which the fruiting body grows outward from the culture medium.
  • the culture medium is sealed with a plastic bag or the like, the physical space outside the sealed container can be obtained. Means space.
  • Fruiting bodies are clusters, umbrellas are fan-shaped to spatula-shaped, 3-8 X 3-10 cm.
  • the surface is hairless and smooth, white to slightly yellowish.
  • the meat is white, 2-5 mm thick. ⁇ is thin and slightly tooth-like.
  • the hypha consists of two hyphae, a thick hypha with a width of 4 to 10 m and a thin hypha with a swelling and twist with a width of 3.5 to 5 m.
  • Spores are intestinal, colorless, 2-2.5 x 5-6.5 m.
  • the water-retaining bodies used in the culture medium include coniferous oakakus derived from conifers such as cedar, hinoki and pine, and oakakus derived from broadleaf trees such as beech, oak and kunugi.
  • coniferous oakakus derived from conifers such as cedar, hinoki and pine
  • oakakus derived from broadleaf trees such as beech, oak and kunugi.
  • corn cob used as a product corn crushed product
  • commercially available bacterial bed materials and the like can be exemplified. These materials may be used alone or as a mixture of two or more. It can also be used.
  • the mixing ratio of the water retaining body and the nutrient for cultivation is preferably in the range of 10: 0.7 to 10: 4, and more preferably in the range of 10: 2 to 3, in terms of fresh weight ratio. Further, the water content may be adjusted to 60 to 70% per final medium, but is more preferably about 65%. Further, as a medium component, soybean hulls, dried yeast, a pH adjuster, and the like, which are usually used for mushroom cultivation, can be added as a medium component.
  • the fungal bed cultivation of B. agarita consists of a pre-culture step, a middle culture step, and a post-culture step, in which the mycelia of B. agaricus grows sufficiently in the medium under specific culture conditions, and the fruiting body is formed.
  • a pre-culture step of obtaining a bacterial bed for formation a medium culture step of culturing the bacterial bed under a specific culture condition to form a B. agaricus primordium, and culturing the formed B. agaricus primordium under a specific culture condition
  • three culturing steps of a post-culturing step of growing to fruiting bodies are employed, and thereby it is possible to obtain fruiting bodies of B. agaricus having a stable content component and the like.
  • the medium culturing step is, as described above, a step performed to form a beech bamboo shoot primordium on the bacterial bed after the completion of the pre-culturing step, and the bacterial bed obtained in the pre-culturing step is heated to a temperature of 8 to 2 hours. 2 ° C, preferably 12 to 16 ° (Humidity 80 to: L 00%, preferably 85 to 95%, illuminance 50 lux or more, preferably 50 to 500 lux When cultivation is continued for 5 to 60 days, for example, Buna hachitake primordium which is not exposed to a physical space capable of growing fruit bodies, such as between the bacterial bed and the inner surface of the container, is formed.
  • the cultivation container 1 having a rectangular cross section or the like is turned sideways so that the Bunakaritake primordium 2a is at the top, and the peripheral portion 5 of the cultivation container in which the It is preferable to harvest the large fruit body 4 of uniform shape by cultivating the fungus body 2a under conditions that expose the physical space where the fungus can grow into fruiting bodies.
  • the agent for preventing and / or improving diabetes mellitus of the present invention includes a fruit body of a mushroom belonging to the family Azotaceae or a processed product thereof, preferably a fruit body of a mushroom belonging to the genus Funeraria or a treated product thereof, and more preferably a fruit body of a fungus or a treated product thereof.
  • Any functional food may be used as long as it is an active ingredient.
  • the functional food of the present invention is not particularly limited as long as it contains such a diabetes preventive / ameliorating agent and has a diabetes preventive / ameliorating action. Not done.
  • the processed substance of the above-mentioned fruiting bodies is not particularly limited.
  • ground fruiting bodies, room-temperature water, hot water, hexane, getyl ether, acetone, black mouth form, methanol, ethanol Extracts of fruiting bodies using, etc. various enzyme-treated products of fruiting bodies, dried fruiting bodies by air drying, hot air drying, heat drying, freeze drying, microwave drying, etc., or dried powder crushed after drying Granules, capsules or tablets of the body or the dried powder by a conventional method Drying of the fruiting body in terms of suppressing the increase in blood glucose level in the fruiting body and improving the yield of components having an effect of improving glucose tolerance, preventing inactivation, and the use form as a food material, etc.
  • the drying method for preparing the dry powder is not particularly limited, but a drying method using a hot air dryer is economically superior, and the drying temperature in such a hot air drying method is 40%. It is preferable to heat at 90 ° C to 90 ° C, especially 60 ° C to 70 ° C for several hours.Drying in this temperature range produces a burning odor and blood glucose level due to the action of enzymes contained in fresh mushrooms. Inhibition of increase ⁇ A decrease in glucose tolerance improving activity can be suppressed. If the harvested fruiting body is not processed immediately, it is preferable to store it at a low temperature of 10 ° C or less, for example, at 4 to 5 ° C.
  • the diabetes preventive and ameliorating agent of the present invention can reduce fasting blood glucose and suppress a rapid increase in blood glucose immediately after ingestion, thereby preventing and improving diabetes such as suppression of blood sugar elevation and suppression of glucose tolerance. Since it has an action, it is advantageously used as a preventive or symptom-improving agent for diabetes, and as a pharmacological composition material for adding the compound to food to make it a functional food having a preventive / improving action for diabetes. be able to.
  • the diabetes preventive ameliorating agent of the present invention usually has a diabetes preventive and ameliorating effect by taking 100 mg to 20 g / kg body weight in terms of dry fruit body per day. The intake can be adjusted appropriately according to the age, etc. When used as a preventive and / or symptom-ameliorating agent for diabetes, for example, it can be mixed with excipients generally used in pharmaceutical applications and used as an orally administered drug.
  • the functional food having the diabetes preventive and ameliorating action of the present invention characterized by containing the diabetes preventive and ameliorating agent of the present invention, uses such a diabetes preventive and ameliorating agent as a part of a raw material for food and drink, Or the manufacturing process or after manufacturing It can be obtained by adding and blending in.
  • Such functional foods are not particularly limited, and include baked goods such as cookies, breads, cakes, rice crackers, etc., tablet confections such as ramune confectionery, Japanese sweets such as yokan, pudding, jelly, ice cream, etc.
  • tablet confections by pulverizing the dried fruit body of the fungus body, and tableting the fine powder according to a conventional method. It can. It is also possible to pulverize the dried fruit body of the fungus body, and mix it with lactose, dextrin, dried yeast and the like.
  • diabetes mellitus model rat Using a model rat of streptozotocin (STZ), a type 1 diabetes mellitus model animal, diabetes mellitus model rat, the preventive effect of the fruit body of B. aeruginosa on diabetes mellitus was examined as follows. Approximately 4 weeks old male SD rats were intraperitoneally administered 65 mg / kg streptozotocin to induce diabetes. One week later, rats that showed hyperglycemia, urinary glucose, heavy eating, and heavy drinking were subjected to the following experiment.
  • STZ model rat of streptozotocin
  • the STZ-diabetic model rats thus prepared were grouped into 8 rats, and a basic diet group to which CRF-1 (Charles River Japan) was administered as a basic diet, and a beech eight described in Example 2 described above so that the basic diet was 5%. They were grouped into a mixed food group of beech agaric mushrooms mixed with the dried powder of mushroom body. They were reared for 4 weeks in an environment in which food and water were freely available at a room temperature of 23 ° C and a 12-hour light / dark cycle. ⁇ Every 1 week from the start of rearing, they were fed from the rat tail vein after a 20-hour fast. Blood was collected and blood glucose was measured. In addition, a glucose tolerance test was performed at weeks 0, 2, and 4. I got it.
  • KKA y diabetes model mice which are a type 2 diabetes model animal
  • the KKA y mouse is a type 2 diabetes model mouse in which the obesity gene A y is introduced into the KK mouse exhibiting hyperglycemia and the obesity and hyperglycemia is expressed. Widely used.
  • KKA y ZT a Jc 1 mice were purchased from Clea Japan, and after one week of preliminary breeding, they were divided into 8 animals per group as in the type 1 diabetes test. The test was started in groups of mixed diets.
  • mice were housed individually in cages at room temperature of 23 ° (:, 12 hours light / dark cycle, with free access to food and water for 5 weeks.
  • Blood was collected from the fundus of the mouse using a capillary blood collection tube, blood glucose was measured, and a glucose tolerance test was performed 5 weeks after the breeding was started, ie, after fasting for 20 hours, 2 g / kg of glucose Blood was collected from the fundus before glucose administration (0 hour), 0.5 hours, 1 hour, 1.5 hours, and 2 hours after glucose administration, and blood glucose levels were measured.
  • the changes in the values are shown in Table 3.
  • the blood glucose level was significantly lower in the Bunahari Yuga mixed diet group, and the increase in the blood glucose level was suppressed.
  • Table 4 Compared to the basic diet group, Bunach In the bamboo mixed diet group, it was confirmed that the increase in blood glucose level immediately after glucose administration was significantly suppressed, and that the blood glucose level was recovered quickly. It was shown.
  • L6 cells used for the test were purchased from Dainippon Pharmaceutical Co., Ltd. L 6 cells were cultured at 3 7 ° C, 5% C_ ⁇ 2 concentration under using carbon dioxide gas incubator at basal medium (D-MEM medium containing 1 0% FBS). Cells in the growth phase were prepared and suspended in a basal medium at 4 ⁇ 10 4 cells / ml. This was added to a 24-multiwell cell culture plate (30464, manufactured by Falcon) in an amount of 1 ml each, and the cells were cultured until they became conferred.
  • the preparation of the Beechari Yuga extract was performed as follows. 0.25 of the dried powder of Beech agaricus described in Example 2 above was mixed with hexane, gethyruether, acetone, 10 ml of form, methanol, ethanol, and water respectively. Add 1 and shake overnight. For hot water extraction, 10 ml of water was added to 0.25 g of the dried powder of Bunakaritake, and the mixture was heated at 105 ° C for 5 minutes using an autoclave. These extracts were filtered with filter paper, and the filtrate was dried under reduced pressure to obtain an extract. Table 5 shows the yields. Hexane, getyl ether, acetone, chloroform, methanol, and ethanol extracts are dimethyl sulfoxide (DI MSO), and water and hot water extracts are water. And dissolved to obtain an extract.
  • DI MSO dimethyl sulfoxide
  • 3T3L1 cells used in the test were purchased from Dainippon Pharmaceutical Co., Ltd.
  • the 3T3L1 cells were cultured in a basal medium (D-MEM medium containing 10% FBS) under a 37,5% C% 2 concentration using a gas carbonate incubator.
  • Cells in the growth phase were prepared and suspended in a basal medium to 5 ⁇ 10 4 Zm 1. This was added to a 24 multi-well cell culture plate every 1 ml, and cultured until it became a confident.
  • the fungus mushroom extract 1 I 1 prepared in Example 5 was added to each medium and cultured.
  • the culture medium was taken out 48 hours after the addition of the extract, and the amount of glucose in the medium was measured.
  • Table 7 shows the amount of Darcos remaining in the medium. As can be seen from Table 7, the amount of glucose was significantly lower in the hexane, getyl ether, acetone, chloroform, and methanol extracts compared to the case without the addition of the Buna mushroom extract in the medium. Was observed. Therefore, it was shown that B. agarita may increase glucose uptake in adipose tissue and decrease blood glucose level.
  • the functional food having the diabetes preventive and ameliorating agent and the diabetes preventive and ameliorating effect of the present invention is derived from a natural product, mushroom, and is highly safe, and has a blood sugar level suppressing effect on type 1 diabetes and type 2 diabetes. Since it has a glucose tolerance improving effect, ingestion of the antitumor agent of the present invention or a functional food having a tumor improving effect can be expected to have a preventive effect on diabetes and a therapeutic effect on diabetes. In addition, by using an artificially cultivated product of Buna hachitake as a fruiting body, it is possible to manufacture an inexpensive and stable agent for preventing and ameliorating diabetes mellitus with stable quality throughout the year.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Diabetes (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Emergency Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Mushroom Cultivation (AREA)

Abstract

Preventives/remedies for diabetes originating in a fungus which is a natural material, having a high safety, a low cost and stable qualities and exhibiting effects of inhibiting an increase in blood glucose level and improving glucose tolerance in type 1 diabetes and type 2 diabetes; and functional foods containing these preventives/remedies for diabetes which have effects of preventing and ameliorating diabetes. The preventives/remedies for diabetes having the effects of inhibiting an increase in blood glucose level and improving glucose tolerance are prepared by using, as the active ingredient, processed fruit body of a fungus belonging to the family Auriscalpiaceae, for example, fruit body of Mycoleptodonoides aitchisonii having been cultured in a mushroom bed. Further, functional foods having an antitumor effect are prepared by adding these preventives/remedies for diabetes to various foods. The effect of inhibiting an increase in blood glucose level can be confirmed by measuring the glucose level in blood after fasting for 16 to 20 hours, while the effect of improving glucose tolerance can be confirmed by carrying out a glucose-load test.

Description

明 細 書 糖尿病予防 ·改善剤及びそれを含む機能性食品 技術分野  Description Diabetes prevention / improvement agent and functional food containing it

本発明は、 糖尿病予防 ·改善剤や糖尿病予防 ·改善作用を有する機能 性食品に関し、 よ り詳しくは、 ブナハリ タケ ( Mycoleptodonoides aitchisonii) 等のェゾハリタケ科 ( Climacodontaceae) のキノコの子実 体から得られる、 1型糖尿病及び 2型糖尿病に対して、 血糖値上昇抑制 効果と耐糖能改善効果を有する糖尿病予防,改善剤や、 かかる糖尿病予 防 ·改善剤を含む糖尿病予防 ·改善作用を有する機能性食品に関する。 背景技術  The present invention relates to a diabetes preventive and ameliorating agent and a functional food having a diabetes preventive and ameliorating effect, and more particularly to a functional food obtained from a fruit body of a mushroom belonging to the family Climacodontaceae, such as Bunakaritake (Mycoleptodonoides aitchisonii). The present invention relates to a diabetes preventive or ameliorating agent having an effect of suppressing an increase in blood glucose level and an effect of improving glucose tolerance against type 1 and type 2 diabetes, and a functional food having a diabetes preventing or ameliorating effect including such a diabetes preventing or ameliorating agent. . Background art

糖尿病とはィンスリン作用の不足による慢性高血糖を主徵とし、 種々 の特徴的な代謝異常を伴う疾患群である。 その発症には遺伝因子と環境 因子がともに関与する。 糖尿病は、 インスリン依存性糖尿病 ( 1型糖尿 病) とインスリン非依存性糖尿病 ( 2型糖尿病) に大別され、 脳卒中や 心臓病の危険因子となることが知られており、 また、 神経障害、 網膜症、 腎臓障害などの合併症による生活の質の低下も重大な問題である。 さら に、 糖尿病の患者数は、 近年急激な増加を示しており、 糖尿病が強く疑 われる人は 6 9 0万人、 糖尿病の可能性を否定できない人を合わせると 1 3 7 0万人になるといわれている。 これは、 生活習慣病として、 国民 の最も重要な健康問題の一つとなっている。  Diabetes is a group of diseases mainly associated with chronic hyperglycemia due to lack of insulin action and associated with various characteristic metabolic abnormalities. Its onset involves both genetic and environmental factors. Diabetes is broadly divided into insulin-dependent diabetes (type 1 diabetes) and non-insulin-dependent diabetes (type 2 diabetes), and is known to be a risk factor for stroke and heart disease. Deterioration of quality of life due to complications such as retinopathy and kidney damage is also a serious problem. In addition, the number of people with diabetes has increased sharply in recent years, with 690,000 people who are strongly suspected of diabetes and 137,000 people who cannot deny the possibility of diabetes. It is said. This is one of the most important health problems of the people as a lifestyle-related disease.

ブナハリタケ (地方名力ミハリタケ) は、 東北地方の深山のブナ林に おいて、 晩秋になるとブナの倒木、 立ち枯れ木に重なり合って生え、 傘 の直径は 3〜 1 0 c m、 半円形で白色、 後に黄色味を帯び、 裏面は白く 針状で、 表面同様、 後に黄色味を帯び、 肉は白くて軟らかく吸水性があ り、 独特の香気をもつことが知られ、 山村の人達から山の肉と呼ばれて 珍重されたキノコとしても知られている。 そして、 ブナ八リタケの人工 栽培方法として、 「長野県林試研究報告」 第 3号、 3 2〜 3 7頁 ( 1 9 8 7 ) 及び 「福島県林試研報」 第 2 3号、 8 1〜 1 0 1頁 ( 1 9 9 0) に は、 ブナ、 サクラ等の原木を用いた栽培に関する研究の報告が、 「食品流 通技術」 V o l . 1 8, N o. 1 , 1 7〜 2 1頁 ( 1 9 8 9) には原木 栽培とォガクズを利用した栽培方法の研究が報告されているが、 これら 報告によると、 原木栽培では子実体に成長させることができるものの、 多くの原木を供給しなければならない上に、 菌糸の腐朽力が強いために 木片で種駒を培養することが難かしいという問題があり、 他方、 ォガク ズを利用した容器栽培では奇形が多く、 またォガクズを利用した袋栽培 では子実体に成長させることが難しく、 いずれにしても従来の技術では 菌床栽培は無理であるとされていた。 In the deep beech forest of the Tohoku region, beech agaric grows on fallen beech trees and dead trees in late autumn, and umbrellas are 3 to 10 cm in diameter, semicircular white, and later. Tint yellow, back white Needle-like, later yellowish on the surface as well as the surface, the meat is white, soft and water-absorbing, and is known to have a unique aroma.As a mushroom prized as mountain meat by mountain villagers Is also known. As methods for artificially cultivating beech hachiritake, Nagano Prefectural Forest Research Report No. 3, pages 32 to 37 (1989) and Fukushima Prefectural Forest Research Report No. 23, 81 On page 101 (1990), a report on research on cultivation using raw wood such as beech and cherry blossoms was published in “Food Flow Technology” Vol. 18, No. 1, 17- On page 1 (19989), there is a report on log cultivation and research on cultivation methods using sawdust. According to these reports, although log cultivation can grow into fruiting bodies, many log Must be supplied, and it is difficult to cultivate seed pieces with wood chips because of the strong decay of mycelia.On the other hand, container cultivation using ogakusu has many malformations, and It is difficult to grow fruiting bodies by bag cultivation using cultivation. It has been considered is the impossible.

本発明の課題は、 1型糖尿病及び 2型糖尿病に対して、 血糖値上昇抑 制効果と耐糖能改善効果を有する糖尿病予防 ·改善剤や、 かかる糖尿病 予防 ·改善剤を含む糖尿病予防 ·改善作用を有する機能性食品を提供す る しとにある。  It is an object of the present invention to provide a diabetes preventive / ameliorating agent having a blood glucose level-inhibiting effect and an glucose tolerance improving effect on type 1 diabetes and type 2 diabetes, and a diabetes preventing / ameliorating effect including such a diabetes preventing / improving agent. To provide a functional food having

本発明者らは、 先に、 ブナハリタケの種菌を特定の栄養源が添加され た培地に接種する接種工程と、 ブナハリタケの種菌が接種された培地を 培養し、 培地に菌糸が生育した菌床を得る前培養工程と、 該菌床を培養 し、 子実体に成長しうる物理的空間に曝されていないブナハリタケ原基 を得る中培養工程と、 該子実体に成長しうる物理的空間に曝されていな いブナハリタケ原基の中から選ばれた原基を、 ブナ八リタケ原基が子実 体に成長しうる物理的空間に曝される条件下で培養し、 ブナハリタケ子 実体を得る後培養工程を経てブナハリタケを栽培すると、 自然に発生す るよりも大型のブナハリタケ子実体が、 周年安定的、 工業的かつ安価に 得られることを確認している (特開 2 0 0 0— 3 0 0 0 6 6号参照)。本 発明者らは、 周年安定的に入手が可能となったブナハリタケ子実体の薬 理作用について種々検討している過程で、 ブナハリタケ子実体の中に、 血糖値上昇抑制作用及び耐糖能改善作用を示す成分が存在することを見 い出し、 本発明を完成するに至った。 発明の開示 The present inventors have previously conducted an inoculation step of inoculating a seed medium of B. agaricus inoculated on a medium supplemented with a specific nutrient source, and culturing the medium inoculated with a seed of B. agaricus, and forming a fungal bed in which the mycelia grew on the medium. A pre-culturing step for obtaining the fungal bed; a middle culturing step for culturing the bacterial bed to obtain a P. aeruginosa primordium that has not been exposed to a physical space capable of growing fruit bodies; and exposing the medium to a physical space capable of growing the fruit bodies. A post-culturing process in which a primordium selected from the original primordial bamboo shoots is cultivated under conditions that expose the physical space in which the primordial cultivars of Buna-haritake can grow into fruiting bodies, to obtain fruiting bodies of Bunakaritake mushrooms Grows naturally after growing beech It has been confirmed that a B. agaricus fruit body that is larger than this can be obtained stably throughout the year, industrially, and inexpensively (see JP-A-2000-3000). The present inventors have been conducting various studies on the pharmacological action of the fruit body of B. aeruginosa, which has been available stably for the whole year, and found that the body of B. aeruginosa has a blood sugar level-inhibiting action and a glucose tolerance improving action. The inventors have found that the components shown are present, and have completed the present invention. Disclosure of the invention

すなわち本発明は、 ェゾハリタケ科 (Climacodontaceae) のキノコの 子実体又はその処理物を有効成分とする糖尿病予防,改善剤(請求項 1 ) や、 ェゾハリタケ科 (Climacodontaceae) のキノコが、 ブナ八リタケ属 (Mycoleptodonoides) のキノコである請求項 1記載の糖尿病予防 · 改 善剤 (請求項 2 ) や、 ブナハリタケ属 (Mycoleptodonoides) のキノコ が、 ブナハリタケ (Mycoleptodonoides aitchisonii) である請求項 2記 載の糖尿病予防 ·改善剤 (請求項 3 ) や、 処理物が乾燥粉体である請求 項 1〜 3のいずれか記載の糖尿病予防 ·改善剤 (請求項 4 ) や、 処理物 が溶媒抽出物である請求項 1〜 3のいずれか記載の糖尿病予防 ·改善剤 (請求項 5 ) や、 ブナハリタケ子実体が人工栽培で得られたブナハリタ ケ子実体であることを特徴とする請求項 3〜 5のいずれか記載の糖尿病 予防 ·改善剤 (請求項 6 ) や、 人工栽培が菌床栽培であることを特徴と する請求項 6記載の糖尿病予防 ·改善剤 (請求項 7 ) や、 菌床栽培が、 保水体と乾燥おから及びビール粕のうち少なくとも一方を含む栽培用栄 養源と水とを混合した培地を滅菌する滅菌工程と、 滅菌した培地にブナ ハリタケの種菌を接種する接種工程と、 ブナハリタケの種菌が接種され た培地を培養し、 培地に菌糸が生育した菌床を得る前培養工程と、 該菌 床を培養し、 子実体に成長しうる物理的空間に曝されていないブナハリ タケ原基を得る中培養工程と、 該子実体に成長しうる物理的空間に曝さ れていないブナ八リタケ原基の中から選ばれた原基を、 ブナ八リタケ原 基が子実体に成長しうる物理的空間に曝される条件下で培養し、 ブナ八 リタケ子実体を得る後培養工程からなることを特徴とする請求項 7記載 の糖尿病予防 ·改善剤 (請求項 8 ) や、 ブナハリタケ子実体が、 ブナ八 リタケ (F E R M B P— 6 6 9 7 ) の子実体であることを特徴とする 請求項 3〜 8のいずれか記載の糖尿病予防 ·改善剤 (請求項 9 ) や、 請 求項 1〜 9のいずれか記載の糖尿病予防 ·改善剤を含んでなる糖尿病予 防 · 改善作用を有する機能性食品 (請求項 1 0 ) に関する。 図面の簡単な説明 That is, the present invention relates to a preventive and ameliorating agent for diabetes comprising a fruit body of a mushroom belonging to the family Crimsonaceae (Climacodontaceae) or a processed product thereof (claim 1), a mushroom belonging to the family Crimsonaceae (Climacodontaceae) belonging to the genus Bunahachitake ( The diabetes preventive and ameliorating agent according to claim 1, which is a mushroom of Mycoleptodonoides) or the mushroom of Mycoleptodonoides, which is a mushroom of Mycoleptodonoides, wherein the mushroom is Mycoleptodonoides aitchisonii. The agent (Claim 3) or the treated product is a dry powder. The preventive and ameliorating agent for diabetes (Claim 4) according to any one of Claims 1 to 3, and the treated product is a solvent extract. The diabetes preventive and ameliorating agent according to any one of claims 3 to 5, and the fruit body of the fungus is a fruit body of a fungus obtained by artificial cultivation. The diabetes preventive and ameliorating agent (Claim 6) and the diabetes preventive and ameliorating agent (Claim 7) according to claim 6, characterized in that the artificial cultivation is bacteria bed cultivation. A sterilization step of sterilizing a medium in which water is mixed with a cultivation nutrient including at least one of dried okara and beer lees; an inoculation step of inoculating the sterilized medium with a B. agaricus inoculum; A pre-culture step of culturing the inoculated medium to obtain a bacterial bed on which the mycelia have grown, and a bunahari that has not been exposed to a physical space capable of culturing the bacterial bed and growing into fruiting bodies. A medium culture step for obtaining bamboo primordia, and a primordium selected from among the Buna hachitake primordium which is not exposed to the physical space where it can grow into the fruiting body. 8. A preventive and ameliorating agent for diabetes mellitus according to claim 7, which comprises a post-culturing step of culturing under conditions exposed to a physical space capable of obtaining a fruit body of Buna-chitake. 9. The diabetes preventive and ameliorating agent (claim 9) according to any one of claims 3 to 8, wherein the fruiting body is a fruit body of Beechachi Ritake (FERMBP-6669). 10. A functional food having a diabetes prevention / amelioration effect, comprising the diabetes prevention / amelioration agent according to any one of 1 to 9 (claim 10). BRIEF DESCRIPTION OF THE FIGURES

第 1図は、 半透明の栽培容器を用いて子実体を形成するブナハリ夕ケ の菌床栽培方法を説明するための図である。 発明を実施するための最良の形態  FIG. 1 is a diagram for explaining a method of cultivating a fungus bed of Bunahari yuga, which forms fruiting bodies using a translucent cultivation container. BEST MODE FOR CARRYING OUT THE INVENTION

本発明に使用されるキノ コ子実体としては、 ブナハ リ タケ属 The mushroom fruit body used in the present invention is

(Mycoleptodonoides) , ェゾハリタケ属 (Climacodon)、 ネバリノ、リヒ ラタケ属 (Donkia) 等のェゾハリタケ科 ( Climacodontaceae) に属す るキノコの子実体であれば特に制限されるものではなく、 具体的には、 ブナノ、 リ タケ ( Mycoleptodonoides aitchisonii ) ゃェゾハ リ タケ(Mycoleptodonoides), Mushrooms belonging to the genus Climacodontaceae (Climacodon), Nebarino, and Rinkita (Donkia) are not particularly limited as long as they are fruit bodies of mushrooms belonging to the family Climacodontaceae. Ritake (Mycoleptodonoides aitchisonii)

、 Climacodon septentrionalis )、 ァケ小ノハ リ タケ 、 Climacodon roseo-maculatum) 等の子実体を例示することができるが、 より優れた 血糖値上昇抑制 ·耐糖能改善作用を有する点でブナハリタケの子実体を 用いることが好ましい。 , Climacodon septentrionalis), Aka small noritake, Climacodon roseo-maculatum) and the like. Preferably, it is used.

上記ブナ八リタケ子実体としては、 自然界に自生する天然の子実体あ るいは人工栽培された子実体のいずれでもよいが、 成分含量等の品質が 安定した人工栽培されたブナハリタケ子実体の方が好ましい。 自然界に 自生する天然のブナ八リタケ子実体では成分含量等が生息地域や気候等 により変動する上に、 周年安定的に収穫することができないが、 人工栽 培されたブナハリタケ子実体では成分含量等が生息地域や気候等により 影響されない上に、 周年安定的に収穫することができる。 また、 人工栽 培方法としては特に限定されないが、 成分含量等の品質が安定したブナ ハリタケを安価かつ周年安定的に収穫することができる菌床栽培の方が 原木栽培よりも好ましい。 ここで、 菌床栽培とは、 原木を用いることな く、 保水体と栄養源からなる素材に種菌を接種し、 温度、 湿度、 照度な どを制御した環境下で栽培する方法をいう。 The fruit body of the Beech Eighth Ritake may be either a natural fruit body that grows naturally in the natural world or a fruit body that is artificially cultivated. Stable artificially cultivated beech agaric fruiting bodies are preferred. The natural beech Hachitake mushroom fruit that grows in the natural world varies in component content depending on the habitat and climate, and cannot be harvested stably throughout the year. Is not affected by the habitat or climate, and can be harvested stably throughout the year. The method of artificial cultivation is not particularly limited, but fungal bed cultivation, which is capable of inexpensively and stably harvesting beech agaricus having stable quality such as component content, is preferable to log cultivation. Here, the fungal bed cultivation refers to a method of inoculating a seed material into a material composed of a water retaining body and a nutrient source without using a log, and cultivating in a controlled environment of temperature, humidity, illuminance, and the like.

かかる菌床栽培の好ましい態様としては、 保水体と、 乾燥おから及び ビール粕のうち少なくとも一方を含む栄養源を含有する栽培用培養源と. 水とを混合した培地を滅菌する滅菌工程と、 滅菌した培地にブナハリ夕 ケの種菌を接種する接種工程と、 ブナハリタケの種菌が接種された培地 を培養し、 培地に菌糸が生育した菌床を得る前培養工程と、 該菌床を培 養し、 子実体に成長しうる物理的空間に曝されていないブナハリタケ原 基を得る中培養工程と、 該子実体に成長しうる物理的空間に曝されてい ないブナ八リタケ原基の中から選ばれた原基を、 ブナハリタケ原基が子 実体に成長しうる物理的空間に曝される条件下で培養し、 ブナハリタケ 子実体を得る後培養工程からなる人工栽培を具体的に例示することがで きる。 ここで、 子実体に成長しうる物理的空間とは、 培養基から外に向 かって子実体が成長する空間を意味し、 例えば培養基をプラスチック製 の袋等により密封した場合には密封容器の外部の空間を意味する。  As preferred embodiments of such fungal bed cultivation, a water retaining body, a culture source for cultivation containing a nutrient source including at least one of dried okara and beer lees, and a sterilization step of sterilizing a medium mixed with water, An inoculation step in which a sterilized medium is inoculated with a fungus inoculated with a fungus, a preculture step in which the medium inoculated with a fungus inoculated with a fungus is obtained, and a culture bed in which hypha grows in the medium is obtained. A medium cultivation step for obtaining a P. agaricus primordium that is not exposed to a physical space capable of growing the fruiting body; and a cultivation primordial primrose that is not exposed to the physical space capable of growing the fruiting body. An artificial cultivation comprising a post-culturing step of cultivating a primordium that is exposed to a physical space in which the fungus can grow into a fruiting body and obtaining a fruiting body of the fungus can be specifically exemplified. . Here, the physical space that can grow into a fruiting body refers to a space in which the fruiting body grows outward from the culture medium.For example, when the culture medium is sealed with a plastic bag or the like, the physical space outside the sealed container can be obtained. Means space.

本発明において用いられるブナハリタケ菌株としては、 そのブナハリ タケの子実体に優れた血糖値上昇抑制及び耐糖能改善効果を示す成分を 含有するブナハリタケに属する菌株であれば市販菌株ゃ自然界から得ら れる菌株をも含めどのような菌株でもよいが、 菌糸生育能及び原基形成 能が優れているブナハリ夕ケ B NH— 3株を用いることが特に好ましい, ブナハリタケ B NH— 3株は、 秋田県南秋田郡の山中で、 枯れ木に自生 していた子実体より、 本発明者らが純粋分離したもので、 ポテトデキス トロース寒天斜面培地での培養物は、 4°C程度の温度下で保存すること ができ、 この保存菌株は 3〜 6ヶ月程度で植え継ぐことが望ましい。 本 菌株の子実体、 菌糸及び胞子の形態学的特徴は次の通りである。 子実体 は群生、 傘は扇形〜へら形で 3〜 8 X 3〜 1 0 c m。 表面は無毛平滑、 白色〜少し黄色味を帯びる。 肉は白色、 厚さ 2〜 5 mm。 緣は薄く多少 歯牙状。 菌糸構成は幅 4〜 1 0 mの厚膜菌糸と、 幅 3. 5〜 5 mで、 ふくらみとねじれをもつ薄膜菌糸の 2菌糸型。 胞子は腸詰め形、 無色、 2〜 2. 5 X 5〜 6. 5 m。 The B. aeruginosa strain used in the present invention may be a commercially available strain obtained from a natural strain as long as it is a strain belonging to the B. aeruginosa containing a component exhibiting an excellent effect of suppressing the increase in blood glucose level and improving glucose tolerance in the fruit body of the B. aeruginosa. Strains may be any strains including the to be, but it is particularly preferable to use Bunahari Yuke B NH- 3 strain mycelium viability and primordia formation ability are good, the Bunaharitake B NH- 3 strains, Minami Akita In the mountains of Akita-gun, the present inventors isolated purely from the fruiting body that had naturally grown on the dead tree, and the culture on the potato dextrose agar slant medium can be stored at a temperature of about 4 ° C. Yes, it is desirable to transfer this stock strain in about 3 to 6 months. The morphological characteristics of the fruiting bodies, hyphae and spores of this strain are as follows. Fruiting bodies are clusters, umbrellas are fan-shaped to spatula-shaped, 3-8 X 3-10 cm. The surface is hairless and smooth, white to slightly yellowish. The meat is white, 2-5 mm thick.緣 is thin and slightly tooth-like. The hypha consists of two hyphae, a thick hypha with a width of 4 to 10 m and a thin hypha with a swelling and twist with a width of 3.5 to 5 m. Spores are intestinal, colorless, 2-2.5 x 5-6.5 m.

上記の形態学的特徴に基づいて、 今関六也、 本郷次雄共著 「原色日本 新菌類図鑑 II」 (保育社平成元年 5月 3 1 日初版発行) により同定する と、 本菌がブナハリタケに属することは明らかである。 なお、 本菌は、 特許手続上の微生物の寄託の国際的承認に関するブタぺスト条約下、 平 成 1 1年 4月 7 日に日本国茨城県つくば巿東 1 一 1 一 1中央第 6に所在 する独立行政法人産業技術総合研究所特許生物寄託センターに F E RM B P— 6 6 9 7として寄託されている。  Based on the morphological characteristics described above, Ryoya Imaseki and Tsuguo Hongo identified the new fungus encyclopedia of Japanese primary colors II (published first edition on May 31, 1989), and found that this fungus was found in Bunakaritake. Clearly belong. This bacterium was established on April 7, 2001 under the Budapest Treaty on International Recognition of the Deposit of Microorganisms for Patent Procedures on April 7, 2011. Deposited as FE RM BP-66697 at the National Institute of Advanced Industrial Science and Technology, Patent Organism Depositary.

ブナハリタケの菌床栽培において、 培地に使用する保水体としては、 スギ、 ヒノキ、 マツ等の針葉樹由来のォガクズや、 ブナ、 ナラ、 クヌギ 等の広葉樹由来のォガクズや、 また、 近年キノコ栽培においてォガクズ 代用品として使用されるコーンコブ (トウモロコシ軸粉砕物) の他、 市 販されている菌床材料等を例示することができ、 これらのものは単独で 使用してもよいし、 2種以上混合して用いることもできる。  In the fungus bed cultivation of Beech agaric, the water-retaining bodies used in the culture medium include coniferous oakakus derived from conifers such as cedar, hinoki and pine, and oakakus derived from broadleaf trees such as beech, oak and kunugi. In addition to corn cob used as a product (corn corn crushed product), commercially available bacterial bed materials and the like can be exemplified. These materials may be used alone or as a mixture of two or more. It can also be used.

また、 ブナハリタケの菌床栽培において、 培地に使用する栽培用栄養 源としては、 ビール粕又は乾燥オカラのいずれかの必須栄養源と、 この 選ばれた必須栄養源以外の他の栄養源とが組み合わされて用いられる。 他の栄養源としては、通常キノコの栽培に用いられる米糠、一般フスマ、 専管フスマ、 コーンブラン等を例示することができる。 ビール粕及び乾 燥オカラを共に含まない栽培用栄養源を培地に使用すると、 菌糸の成長 が遅いばかりでなく、 大きさや形に優れた子実体を得ることが困難とな る。 In addition, in the fungus bed cultivation of the fungus beech, As a source, an essential nutrient of either beer lees or dried okara is used in combination with other nutrients other than the selected essential nutrient. Examples of other nutrient sources include rice bran, general bran, dedicated bran, corn bran and the like which are usually used for cultivation of mushrooms. When a nutrient for cultivation that does not contain both beer lees and dried okara is used in the culture medium, not only the growth of mycelia is slow, but also it becomes difficult to obtain fruit bodies that are excellent in size and shape.

上記保水体と栽培用栄養源との混合割合は、 生重量比で 1 0 : 0 . 7 〜 1 0 : 4の範囲が好ましく、 1 0 : 2〜 3の範囲が特に好ましい。 ま た、水分含量は最終培地あたり 6 0〜 7 0 %に調整すればよいが、 6 5 % 程度にするのがより好ましい。 さらに、 培地成分として、 通常キノコ栽 培で用いられている大豆皮、 乾燥酵母や p H調整剤等を培地成分として 添加することもできる。  The mixing ratio of the water retaining body and the nutrient for cultivation is preferably in the range of 10: 0.7 to 10: 4, and more preferably in the range of 10: 2 to 3, in terms of fresh weight ratio. Further, the water content may be adjusted to 60 to 70% per final medium, but is more preferably about 65%. Further, as a medium component, soybean hulls, dried yeast, a pH adjuster, and the like, which are usually used for mushroom cultivation, can be added as a medium component.

ブナハリタケの菌床栽培は、 前述したように、 前培養工程と中培養ェ 程と後培養工程からなり、 培地中にブナ八リタケの菌糸を特定の培養条 件下で充分に生育させ、 子実体形成のための菌床を得る前培養工程と、 該菌床に特定の培養条件下で培養し、 ブナハリタケ原基を形成させる中 培養工程と、 形成したブナハリタケ原基を特定の培養条件下で培養し、 子実体まで成長させる後培養工程の 3つの培養工程を採用しており、 こ れにより含量成分等の品質が安定したブナハリタケの子実体を得ること ができる。  As described above, the fungal bed cultivation of B. agarita consists of a pre-culture step, a middle culture step, and a post-culture step, in which the mycelia of B. agaricus grows sufficiently in the medium under specific culture conditions, and the fruiting body is formed. A pre-culture step of obtaining a bacterial bed for formation, a medium culture step of culturing the bacterial bed under a specific culture condition to form a B. agaricus primordium, and culturing the formed B. agaricus primordium under a specific culture condition However, three culturing steps of a post-culturing step of growing to fruiting bodies are employed, and thereby it is possible to obtain fruiting bodies of B. agaricus having a stable content component and the like.

前培養工程は、 保水体と栽培用栄養源と水とを含有する培地を加圧滅 菌後、 ブナハリタケの種菌を接種し、 温度 1 5〜 3 5 、 好ましくは 2 1〜 2 7 °Cで、 湿度 4 0〜 8 0 %、 好ましくは 6 0〜 7 0 %付近で、 暗 条件下で培養し、 培地中に菌糸を蔓延させ、 子実体が発生するための栄 養源を菌糸に蓄積させる工程である。 培養熟成日数、 すなわち培地全体 に菌糸が蔓延するのに要する日数と栄養源を菌糸に蓄積させるのに必要 な日数は、 1. 2 k g用袋を用いた場合、 2 5〜 9 0日間が好ましく、 通常 2 5日間未満では子実体は発生しないか、 後の中培養工程で著しく 曰数を要する。 この際、 用いる培養容器の大きさゃ種菌接種量により前 培養工程に要する日数が変化することはいうまでもない。 In the pre-culture step, a medium containing a water retention body, a nutrient for cultivation, and water is sterilized under pressure, and then an inoculum of B. agaricus is inoculated at a temperature of 15 to 35, preferably 21 to 27 ° C. Cultivation under dark conditions at a humidity of 40 to 80%, preferably 60 to 70%, spreads mycelia in the medium, and accumulates nutrients for the generation of fruiting bodies. It is a process. Culture ripening days, ie whole medium The number of days required for mycelia to spread and the number of days required for nutrients to accumulate in the mycelium is preferably 25 to 90 days when a 1.2 kg bag is used, and usually less than 25 days. No fruiting body is generated, or it requires a significant number in the later medium culture process. At this time, it goes without saying that the number of days required for the pre-culture step varies depending on the size of the culture vessel used and the amount of the inoculum inoculated.

中培養工程は、 前記のように、 前培養工程終了後の菌床にブナ八リタ ケ原基を形成させるために行う工程であり、 前培養工程で得られた菌床 を、 温度 8〜 2 2°C、 好ましくは 1 2〜 1 6° ( 、 湿度 8 0〜 : L 0 0 %、 好ましくは 8 5〜 9 5 %、 照度 5 0ルックス以上、 好ましくは 5 0〜 5 0 0ルックスで 2 5〜 6 0日間培養を続けると、 例えば、 菌床と容器内 面との間等の子実体に成長しうる物理的空間に曝されていないブナ八リ タケ原基が形成する。  The medium culturing step is, as described above, a step performed to form a beech bamboo shoot primordium on the bacterial bed after the completion of the pre-culturing step, and the bacterial bed obtained in the pre-culturing step is heated to a temperature of 8 to 2 hours. 2 ° C, preferably 12 to 16 ° (Humidity 80 to: L 00%, preferably 85 to 95%, illuminance 50 lux or more, preferably 50 to 500 lux When cultivation is continued for 5 to 60 days, for example, Buna hachitake primordium which is not exposed to a physical space capable of growing fruit bodies, such as between the bacterial bed and the inner surface of the container, is formed.

後培養工程は、 上記のように、 中培養工程終了後の子実体に成長しう る物理的空間に曝されていないブナハリタケ原基を子実体へ成長させる ために行う工程であり、 中培養工程で得られた子実体に成長しうる物理 的空間に曝されていないブナ八リタケ原基が形成されている。 例えば、 容器の周辺箇所を取り除き、温度 8〜 2 2°C、好ましくは 1 2〜 1 6°C、 湿度 8 0〜 1 0 0 %、好ましくは 8 5〜 9 5 %、 照度 5 0ルックス以上、 好ましくは 5 0〜 5 0 0ルックスで、 かつブナ八リ夕ケ原基が子実体に 成長しうる物理的空間に曝される条件下で 5 ~ 2 0日間培養を続けると ブナ八リ夕ケ原基が子実体へと成長する。  As described above, the post-culture step is a step performed to grow a P. aeruginosa primordium, which has not been exposed to the physical space that can grow into the fruit body after the completion of the middle culture step, into a fruit body. A beech bamboo shoot primordium is formed which is not exposed to the physical space that can grow on the fruiting body obtained in step (1). For example, remove the surrounding area of the container, temperature 8 ~ 22 ° C, preferably 12 ~ 16 ° C, humidity 80 ~ 100%, preferably 85 ~ 95%, illuminance 50 lux or more Culturing for 5 to 20 days, preferably at 50 to 500 lux, and under conditions where the primordium beech is exposed to a physical space where it can grow into fruiting bodies, Ke primordia grow into fruiting bodies.

ブナハリタケの栽培には、 培地の滅菌の簡易さ等から、 栽培容器が通 常用いられ、 また栽培容器には栽培袋等も含まれる。 図 1に示すように、 栽培容器 1 としては、 形成されたブナハリタケ原基 2を容器外側から肉 眼で観察することができるように、 透明又は半透明の材質からなる容器 が好ましい。 また、 菌床 3と栽培容器 1内面との間に形成された、 子実 体に成長しうる物理的空間に曝されていないブナハリタケ原基の中から 選ばれた直径 3 c m程度の 1つのブナハリ夕ケ原基 2 aを培養すること が自然に発生するブナハリタケより大きな子実体 4を得る上で好ましい < さらに、 横断面が矩形等の栽培容器 1を横に倒し、 ブナハリタケ原基 2 aが上になるようにして、 ブナハリタケ原基が形成された栽培容器の周 辺箇所 5を切除し、 ブナハリタケ原基が子実体に成長しうる物理的空間 に曝される条件下でブナハリタケ原基 2 aを培養することが形の揃った 大型の子実体 4を収穫する上で好ましい。 For cultivation of Buna mushrooms, cultivation vessels are usually used because of the simplicity of sterilization of the culture medium, and cultivation vessels include cultivation bags. As shown in FIG. 1, the cultivation container 1 is preferably a container made of a transparent or translucent material so that the formed beech agaric primordium 2 can be visually observed from the outside of the container. In addition, grain formed between the fungal bed 3 and the inner surface of the cultivation vessel 1 Cultivating one Bunakari Yuga primordium 2a with a diameter of about 3 cm selected from among the Bunakaritake primordia that are not exposed to the physical space that can grow in the body. It is preferable to obtain <4.Furthermore, the cultivation container 1 having a rectangular cross section or the like is turned sideways so that the Bunakaritake primordium 2a is at the top, and the peripheral portion 5 of the cultivation container in which the It is preferable to harvest the large fruit body 4 of uniform shape by cultivating the fungus body 2a under conditions that expose the physical space where the fungus can grow into fruiting bodies.

本発明の糖尿病予防 ·改善剤としては、 ェゾハリタケ科のキノコの子 実体又はその処理物、 好ましくはブナハリタケ属のキノコの子実体又は その処理物、 より好ましくはブナハリタケの子実体又はその処理物を有 効成分とするものであればどのようなものでもよく、 また、 本発明の機 能性食品としては、 かかる糖尿病予防 ·改善剤を含み、 糖尿病予防 ·改 善作用を有する食品であれば特に制限されない。 ここで、 糖尿病予防 · 改善作用 (効果) とは、 空腹時血糖値の上昇抑制による血糖値上昇抑制 作用 (効果) と、 摂食直後の急激な血糖値の上昇抑制による耐糖能改善 作用 (効果) とをいい、 かかる血糖値上昇抑制効果は、 例えば、 1 6時 間から 2 0時間の絶食の後、 血中に含まれるグルコース濃度を測定する ことにより確認することができ、 また、 耐糖能改善効果は、 グルコース 負荷試験を行うことにより確認することができる。  The agent for preventing and / or improving diabetes mellitus of the present invention includes a fruit body of a mushroom belonging to the family Azotaceae or a processed product thereof, preferably a fruit body of a mushroom belonging to the genus Funeraria or a treated product thereof, and more preferably a fruit body of a fungus or a treated product thereof. Any functional food may be used as long as it is an active ingredient. The functional food of the present invention is not particularly limited as long as it contains such a diabetes preventive / ameliorating agent and has a diabetes preventive / ameliorating action. Not done. Here, diabetes prevention and amelioration effect (effect) refers to the effect of suppressing the increase in blood glucose level by suppressing the increase in fasting blood glucose level (effect) and the effect of improving glucose tolerance by suppressing the rapid increase in blood glucose level immediately after eating (effect) The effect of suppressing an increase in blood glucose level can be confirmed, for example, by measuring the concentration of glucose contained in blood after a fast of 16 hours to 20 hours. The improvement effect can be confirmed by performing a glucose tolerance test.

上記子実体の処理物としては特に制限されるものではなく、 例えば、 子実体の磨碎物や、 常温水、 熱水、 へキサン、 ジェチルエーテル、 ァセ トン、 クロ口ホルム、 メタノール、 エタノール等を用いた子実体の抽出 物や、 子実体の各種酵素処理物や、 風乾、 熱風乾燥、 加熱乾燥、 凍結乾 燥、 マイクロ波乾燥等による子実体の乾燥物や、 乾燥後に粉砕した乾燥 粉体や、 該乾燥粉体を常法により顆粒化、 カプセル化、 錠剤化したもの などを挙げることができるが、 子実体中の血糖値上昇抑制及び耐糖能改 善効果を有する成分の収率向上、 不活性化防止、 食品素材としての使用 形態等の点で、 子実体の乾燥粉体、 子実体の溶媒抽出物等が好ましい。 乾燥粉体を調製する場合の乾燥方法としては特に制限されるものではな いが、 熱風乾燥機を用いる乾燥方法が経済的には優れており、 かかる熱 風乾燥方法における乾燥温度としては 4 0〜 9 0 °C、 特に 6 0〜 7 0 °C で数時間加熱することが好ましく、この温度範囲で乾燥することにより、 焦げ臭の発生や、 生鮮キノコ中に含まれる酵素の作用による血糖値上昇 抑制 ·耐糖能改善活性の低下を抑制することができる。 また、 収穫した 子実体をすぐに加工処理しない場合は、 1 0 °C以下の低温、 例えば 4〜 5 °Cにて保存することが好ましい。 The processed substance of the above-mentioned fruiting bodies is not particularly limited. For example, ground fruiting bodies, room-temperature water, hot water, hexane, getyl ether, acetone, black mouth form, methanol, ethanol Extracts of fruiting bodies using, etc., various enzyme-treated products of fruiting bodies, dried fruiting bodies by air drying, hot air drying, heat drying, freeze drying, microwave drying, etc., or dried powder crushed after drying Granules, capsules or tablets of the body or the dried powder by a conventional method Drying of the fruiting body in terms of suppressing the increase in blood glucose level in the fruiting body and improving the yield of components having an effect of improving glucose tolerance, preventing inactivation, and the use form as a food material, etc. Powders, solvent extracts of fruiting bodies and the like are preferred. The drying method for preparing the dry powder is not particularly limited, but a drying method using a hot air dryer is economically superior, and the drying temperature in such a hot air drying method is 40%. It is preferable to heat at 90 ° C to 90 ° C, especially 60 ° C to 70 ° C for several hours.Drying in this temperature range produces a burning odor and blood glucose level due to the action of enzymes contained in fresh mushrooms. Inhibition of increase · A decrease in glucose tolerance improving activity can be suppressed. If the harvested fruiting body is not processed immediately, it is preferable to store it at a low temperature of 10 ° C or less, for example, at 4 to 5 ° C.

本発明の糖尿病予防 ·改善剤は、 空腹時血糖値を低下させ、 摂食直後 の急激な血糖値の上昇を抑えることができ、 血糖値上昇抑制ゃ耐糖能の 低下抑制などの糖尿病予防 ·改善作用を有することから、 糖尿病の予防 剤や症状改善剤として、 さらに食品に添加配合することにより該食品を 糖尿病予防 ·改善作用を有する機能性食品とするための薬理組成物素材 として、 有利に用いることができる。 そして、 本発明の糖尿病予防 '改 善剤は、 通常、 乾燥子実体換算で 1 0 0 m g〜 2 0 g / k g体重 · 日摂 取することにより糖尿病予防 ·改善作用をもたらすが、 症状、 性別、 年 齢等に応じて、 摂取量は適宜調整することができる。 そしてまた、 糖尿 病の予防及び 又は症状改善剤として用いる場合は、 例えば製薬上一般 的に用いられている賦形剤と混合して通常経口投与剤として用いること ができる。  The diabetes preventive and ameliorating agent of the present invention can reduce fasting blood glucose and suppress a rapid increase in blood glucose immediately after ingestion, thereby preventing and improving diabetes such as suppression of blood sugar elevation and suppression of glucose tolerance. Since it has an action, it is advantageously used as a preventive or symptom-improving agent for diabetes, and as a pharmacological composition material for adding the compound to food to make it a functional food having a preventive / improving action for diabetes. be able to. The diabetes preventive ameliorating agent of the present invention usually has a diabetes preventive and ameliorating effect by taking 100 mg to 20 g / kg body weight in terms of dry fruit body per day. The intake can be adjusted appropriately according to the age, etc. When used as a preventive and / or symptom-ameliorating agent for diabetes, for example, it can be mixed with excipients generally used in pharmaceutical applications and used as an orally administered drug.

上記本発明の糖尿病予防 ·改善剤を含有することを特徴とする本発明 の糖尿病予防 ·改善作用を有する機能性食品は、 かかる糖尿病予防 ·改 善剤を飲食品原料の一部として用いたり、 あるいは製造工程又は製造後 に添加 ·配合することにより得ることができる。 かかる機能性食品とし ては特に制限されるものではなく、 クッキ一、 パン、 ケーキ、 煎餅など の焼き菓子、 ラムネ菓子等などの錠菓、 羊羹などの和菓子、 プリン、 ゼ リー、 アイスクリーム類などの冷菓、 チューインガム、 キャンディ等の 菓子類や、 クラッカ一、 チップス等のスナック類や、 うどん、 そば等の 麵類や、 かまぼこ、 ハム、 魚肉ソ一セージ等の魚肉練り製品や、 チーズ、 バタ一などの乳製品や、 みそ、 しょう油、 ドレッシング、 マヨネーズ、 甘味料等の調味類や、 豆腐、 こんにゃく、 その他佃煮、 餃子、 コロッケ、 サラダ、 スープ、 シチュー等の各種総菜や、 ヨーグルト、 ドリンクョ一 ダルト、 ジュース、 牛乳、 豆乳、 酒類、 コーヒー、 紅茶、 煎茶、 ゥ一口 ン茶、スポーツ飲料等の各種飲料などを具体的に例示することができる。 例えば、 ブナハリタケ子実体乾燥品を微粉末化し、 該微粉末を常法に従 い打錠することにより錠菓を製造することができ、 この場合かかる微粉 末を造粒した後に打錠することもできる。 また、 ブナハリタケ子実体乾 燥品を微粉末化し、 これに乳糖、 デキストリン、 乾燥酵母等を配合した ものを打錠することもできる。 The functional food having the diabetes preventive and ameliorating action of the present invention, characterized by containing the diabetes preventive and ameliorating agent of the present invention, uses such a diabetes preventive and ameliorating agent as a part of a raw material for food and drink, Or the manufacturing process or after manufacturing It can be obtained by adding and blending in. Such functional foods are not particularly limited, and include baked goods such as cookies, breads, cakes, rice crackers, etc., tablet confections such as ramune confectionery, Japanese sweets such as yokan, pudding, jelly, ice cream, etc. Confectionery such as frozen desserts, chewing gum, candy, etc., snacks such as crackers, chips, etc., 麵 such as udon, buckwheat, etc., fish paste products such as kamaboko, ham, fish meat sausage, cheese, butter, etc. Dairy products, miso, soy sauce, dressing, mayonnaise, sweeteners, and other seasonings, tofu, konjac, other tsukudani, gyoza, croquettes, salads, soups, stews, etc. , Milk, soy milk, alcoholic beverages, coffee, black tea, green tea, green tea, sports drinks, etc. It can be specifically exemplified. For example, it is possible to produce tablet confections by pulverizing the dried fruit body of the fungus body, and tableting the fine powder according to a conventional method. it can. It is also possible to pulverize the dried fruit body of the fungus body, and mix it with lactose, dextrin, dried yeast and the like.

以下に、 実施例を掲げてこの発明を更に具体的に説明するが、 この発 明の範囲はこれらの例示に限定されるものではない。  Hereinafter, the present invention will be described more specifically with reference to examples, but the scope of the present invention is not limited to these examples.

実施例 1 [ブナハリタケの菌床栽培] Example 1 [Bacterial bed cultivation of Bunakaritake]

ブナォガクズ 3 8 0 g、 乾燥ビール粕 3 7 . 5 g、 乾燥おから 3 7 . 5 g、水道水 5 4 5 gを混合した計 1 0 0 0 gを、 1 . 2 k g用 P P (ポ リプロピレン) 製袋に詰めて培地を作製した。 さらにこの袋にフィルタ 一をはさんだポリプロピレン製キャップをして 1 2 1 °C、 5 0分加圧滅 菌し、 滅菌後の培地を冷却した後、 ブナハリタケ (F E R M B P— 6 6 9 7 )の種菌を接種し、暗所にて温度 2 3〜 2 5 °C、湿度 6 0〜 8 0 % の条件で 4 0日間前培養を行い、 次に中培養工程へ移行した。 中培養ェ 程では、 温度 1 3〜 1 5 °C、 湿度 8 0〜 9 5 %、 照度 2 0 0ルックスの 条件下で、 3 0 日間培養するとブナハリタケ原基が形成された。 袋内に 直径約 3 c m程度の原基が認められる部分の袋部の 1箇所を切り取り、 次いで後培養工程へ移行した。 後培養工程では、 温度 1 3〜 1 5°C、 湿 度 8 0〜 9 5 %、 照度 2 0 0ルックスの条件下で、 1 7 日間培養すると 1株のブナハリタケ子実体へと成長した。 得られたブナハリタケ子実体 は 2 3 2. 5 gで、 栽培に要した総日数は 8 7 日であった。 A total of 100 g, which is a mixture of 380 g of Bunagaguzu, 37.5 g of dried beer lees, 37.5 g of dried okara, and 545 g of tap water, is added to a 1.2 kg PP (poly) Propylene) The medium was prepared by filling the bag. The bag is covered with a polypropylene cap sandwiching a filter, sterilized under pressure at 121 ° C for 50 minutes, and the sterilized medium is cooled. The seeds of Bunakaritake (FERMBP—66997) , And pre-cultured in a dark place at a temperature of 23 to 25 ° C and a humidity of 60 to 80% for 40 days, and then shifted to a medium culture step. Medium culture In this process, cultivation of B. agarita primordium was carried out for 30 days at a temperature of 13 to 15 ° C, a humidity of 80 to 95%, and an illuminance of 200 lux. One portion of the bag where the primordium with a diameter of about 3 cm was observed was cut off, and the process was shifted to the post-culture step. In the post-culture step, the strain grew to a single fruit body of B. agaricus after culturing for 17 days under the conditions of a temperature of 13 to 15 ° C, a humidity of 80 to 95%, and an illuminance of 200 lux. The obtained fruit body of B. agaricus was 232.5 g, and the total number of days required for cultivation was 87 days.

実施例 2 [ブナハリタケ子実体乾燥粉末の調製] Example 2 [Preparation of dried powder of fruit body of B. agaricus]

上記菌床栽培にて得られたブナ八リタケ子実体 3 k gを、 収穫後直ち に 4°Cにて最長 1週間まで冷蔵保存しておき、 熱風乾燥機にて 6 5°Cで 6時間乾燥処理を行い、 ブナハリタケ子実体乾燥品 0. 3 k gを得た。 ブナハリ夕ケ子実体乾燥品は粉砕機を用いて粉碎し、 ブナ八リ夕ケ子実 体乾燥粉末とした。  Immediately after harvesting, 3 kg of the fruit body of Beech Hachiritake obtained from the above-described fungal bed cultivation is stored refrigerated at 4 ° C for up to 1 week, and then heated at 65 ° C for 6 hours using a hot air dryer. Drying was carried out to obtain 0.3 kg of a dried product of the fruit body of the fungus. The dried beechari yuga fruit body was pulverized using a crusher to obtain a dried powder of the beech body.

実施例 3 [ 1型糖尿病に対する効果] Example 3 [Effect on Type 1 Diabetes]

1型糖尿病モデル動物の一種であるストレブトゾトシン (S T Z) 糖 尿病モデルラッ トを用いてブナハリタケ子実体の糖尿病予防効果を次の ようにして調べた。 約 4週齢の雄の S Dラットに 6 5 mg/k gのスト レブトゾトシンを腹腔内に投与し、 糖尿病を誘発させた。 1週間後に高 血糖、 尿糖、 多食、 多飲を示したラットについて以下の実験に供した。 作製した S T Z糖尿病モデルラットを 1群 8匹とし、 基本食として C R F— 1 (日本チャールズリバ一) を投与した基本食群と、 基本食に 5 % となるように上記実施例 2記載のブナ八リタケ子実体乾燥粉末を混合し たブナハリタケ混合食群とに群分けした。 これらを室温 2 3°C、 1 2時 間明暗サイクルにて飼料と水を自由に摂取できる環境で 4週間飼育した < 飼育開始から 1週間毎に、 2 0時間絶食後のラッ ト尾静脈より採血し、 血糖値を測定した。 さらに、 0、 2、 4週目ではブドウ糖負荷試験を行 つた。 すなわち、 2 0時間の絶食後、 2 g / k gのブドウ糖をゾンデを 用いて経口投与した。 ブドウ糖投与前 ( 0時間)、 投与後 0 . 5時間、 1 時間、 1 . 5時間、 2時間後にそれぞれ尾静脈から採血し血糖値を測定 した。 血糖値の測定はグルコース C I I 一テストヮコ一 (和光純薬株式 会社) を用いて実施した。 Using a model rat of streptozotocin (STZ), a type 1 diabetes mellitus model animal, diabetes mellitus model rat, the preventive effect of the fruit body of B. aeruginosa on diabetes mellitus was examined as follows. Approximately 4 weeks old male SD rats were intraperitoneally administered 65 mg / kg streptozotocin to induce diabetes. One week later, rats that showed hyperglycemia, urinary glucose, heavy eating, and heavy drinking were subjected to the following experiment. The STZ-diabetic model rats thus prepared were grouped into 8 rats, and a basic diet group to which CRF-1 (Charles River Japan) was administered as a basic diet, and a beech eight described in Example 2 described above so that the basic diet was 5%. They were grouped into a mixed food group of beech agaric mushrooms mixed with the dried powder of mushroom body. They were reared for 4 weeks in an environment in which food and water were freely available at a room temperature of 23 ° C and a 12-hour light / dark cycle. <Every 1 week from the start of rearing, they were fed from the rat tail vein after a 20-hour fast. Blood was collected and blood glucose was measured. In addition, a glucose tolerance test was performed at weeks 0, 2, and 4. I got it. That is, after a 20-hour fast, 2 g / kg glucose was orally administered using a sonde. Blood was collected from the tail vein before glucose administration (0 hour) and 0.5 hours, 1 hour, 1.5 hours, and 2 hours after administration, and blood glucose levels were measured. The blood glucose level was measured using Glucose CII One Test Co., Ltd. (Wako Pure Chemical Industries, Ltd.).

試験期間中の空腹時血糖値の変化を表 1に、 ブドウ糖負荷試験の結果 を表 2にそれぞれ示す。 表 1からわかるように、 基本食群と比較してブ ナ八リ夕ケ混合食群では、空腹時血糖値の上昇が抑えられ試験終了時に、 血糖値は有意に低下していた。 また、 表 2から、 試験開始時には 2群間 に差はないが、 2週目、 4週目ではブドウ糖投与直後の血糖値の上昇が 抑えられ、 さらに血糖値の回復も早く、 従って、 基本食群と比較してブ ナ八リタケ混合食群では、 耐糖能が改善されていることがわかる。 以上 のことからブナハリタケには 1型糖尿病の予防 ·改善効果があることが 示された。  The changes in fasting blood glucose during the test period are shown in Table 1, and the results of the glucose tolerance test are shown in Table 2. As can be seen from Table 1, the increase in fasting blood glucose was suppressed in the Beech Hachiriyuga mixed diet group compared to the basic diet group, and the blood glucose level was significantly decreased at the end of the test. Also, from Table 2, there is no difference between the two groups at the start of the test, but in the second and fourth weeks, the rise in blood glucose immediately after glucose administration was suppressed, and the recovery of blood glucose was quick, and therefore, the basic diet It can be seen that the glucose tolerance is improved in the mixed group of beech and garland mushrooms compared to the group. From the above, it was shown that B. agarita has preventive and ameliorating effects on type 1 diabetes.

表 1 table 1

Figure imgf000015_0001
表 2 血糖値 (ms/dl)
Figure imgf000015_0001
Table 2 Blood glucose (ms / dl)

期間 投与群 採血時間(時間 )  Duration Treatment group Blood sampling time (hours)

0.0 0.5 1.0 1.5 2.0 0.0 0.5 1.0 1.5 2.0

0週目 基本食群 1 15.1 ± 12.8 410.3± 15.2 概 5 ± 19.2 319.6 ± 19.9 236.4±23.8 ブナハリタケ混合食群 132.0± 18.3 449.7±26.7 420.4±30.4 304.0 ±40.0 208.2±36.1Week 0 Basic diet group 1 15.1 ± 12.8 410.3 ± 15.2 Approx. 5 ± 19.2 319.6 ± 19.9 236.4 ± 23.8 Bunakaritake mixed diet group 132.0 ± 18.3 449.7 ± 26.7 420.4 ± 30.4 304.0 ± 40.0 208.2 ± 36.1

18.5 18.5

2週目 基本食群 314.4±39.9 620.4±26.8 597.9± 19.9 538.6± 16.5 500.9± Week 2 Basic food group 314.4 ± 39.9 620.4 ± 26.8 597.9 ± 19.9 538.6 ± 16.5 500.9 ±

ブナハリタケ混合食群 238.2±57.8 453.8 + 25.3* 484.0±25.8* 41 1.7±38.8伞 370.4±50.5* Beech agaric mixed diet group 238.2 ± 57.8 453.8 + 25.3 * 484.0 ± 25.8 * 41 1.7 ± 38.8 伞 370.4 ± 50.5 *

8.2 608.9土 17.5 572.3± 19.4 8.2 608.9 Sat 17.5 572.3 ± 19.4

4週目 基本食群 492.8±43.4 801.4+43.1 727.0±2 Week 4 Basic diet group 492.8 ± 43.4 801.4 + 43.1 727.0 ± 2

ブナハリタケ混合食群 353.3±69.8* 626.3±49.9* 647.3±48.4 521.6±31.1 * 456.0±39.6* Beech agaric mixed diet group 353.3 ± 69.8 * 626.3 ± 49.9 * 647.3 ± 48.4 521.6 ± 31.1 * 456.0 ± 39.6 *

* :危 i貧率 5%で有意差あり 実施例 4 [ 2型糖尿病に対する効果] *: There is a significant difference at risk of 5% Example 4 [Effect on Type 2 Diabetes]

2型糖尿病モデル動物の一種である K K A y糖尿病モデルマウスを用 い 1型糖尿病と同様にブナ八リタケ子実体の効果を次のようにして調べ た。 K K A yマウスは、 高血糖を呈する K Kマウスに肥満遺伝子 A yが導 入され肥満、 高血糖を発現する 2型糖尿病モデルマウスであり、 日本人 の糖尿病発現に類似していることからモデル動物として広く使われてい る。 約 4週齢の雄の K K A y Z T a J c 1 マウスを日本クレアから購 入し、 1週間の予備飼育の後、 1型糖尿病の試験と同様に 1群 8匹とし、 基本食群とブナハリタケ混合食群に群分けして試験を開始した。 マウス はケージに個別に入れて室温 2 3 ° (:、 1 2時間明暗サイクルにて飼料と 水を自由に摂取できる環境で 5週間飼育した。飼育開始から 1週間毎に、 5時間絶食後のマウス眼底からキヤビラリ一採血管をもちいて採血し、 血糖値を測定した。 さらに、 飼育開始から 5週間後にブドウ糖負荷試験 を行った。 すなわち 2 0時間絶食した後、 2 g / k gのブドウ糖をゾン デを用いて経口投与した。 ブドウ糖投与前 ( 0時間)、 投与後 0 . 5時間, 1時間、 1 . 5時間、 2時間後に眼底から採血し血糖値を測定した。 試 験期間中の血糖値の変化を表 3に示す。 基本食群と比較してブナハリ夕 ケ混合食群では、 血糖値は有意に低下しており、 血糖値の上昇が抑えら れていた。 また、 ブドウ糖負荷試験の結果を表 4に示す。 基本食群と比 較して、 ブナハリタケ混合食群では、 ブドウ糖投与直後の血糖値の上昇 が有意に抑えられ、 さらに血糖値の回復も早いことが確認された。 以上 のことからブナハリタケには 2型糖尿病の予防 ·改善効果があることが 示された。 Using KKA y diabetes model mice, which are a type 2 diabetes model animal, the effect of the fruit body of Buna hachitake was examined in the same manner as in type 1 diabetes as follows. The KKA y mouse is a type 2 diabetes model mouse in which the obesity gene A y is introduced into the KK mouse exhibiting hyperglycemia and the obesity and hyperglycemia is expressed. Widely used. Approximately 4 weeks old male KKA y ZT a Jc 1 mice were purchased from Clea Japan, and after one week of preliminary breeding, they were divided into 8 animals per group as in the type 1 diabetes test. The test was started in groups of mixed diets. Mice were housed individually in cages at room temperature of 23 ° (:, 12 hours light / dark cycle, with free access to food and water for 5 weeks. Blood was collected from the fundus of the mouse using a capillary blood collection tube, blood glucose was measured, and a glucose tolerance test was performed 5 weeks after the breeding was started, ie, after fasting for 20 hours, 2 g / kg of glucose Blood was collected from the fundus before glucose administration (0 hour), 0.5 hours, 1 hour, 1.5 hours, and 2 hours after glucose administration, and blood glucose levels were measured. The changes in the values are shown in Table 3. Compared to the basic diet group, the blood glucose level was significantly lower in the Bunahari Yuga mixed diet group, and the increase in the blood glucose level was suppressed. The results are shown in Table 4. Compared to the basic diet group, Bunach In the bamboo mixed diet group, it was confirmed that the increase in blood glucose level immediately after glucose administration was significantly suppressed, and that the blood glucose level was recovered quickly. It was shown.

4 表 3 Four Table 3

Figure imgf000017_0001
表 4
Figure imgf000017_0001
Table 4

Figure imgf000017_0002
実施例 5 [筋細胞に対する効果]
Figure imgf000017_0002
Example 5 [Effect on muscle cells]

ラッ ト骨格筋由来の筋芽細胞 L 6を用いてブナハリタケの筋細胞に対 するグルコース取り込み促進効果を示した。 試験に使用する L 6細胞は 大日本製薬株式会社から購入した。 L 6細胞は、 基本培地 ( 1 0 % F B Sを含む D— MEM培地) で炭酸ガスインキュベータを用いて 3 7 °C, 5 % C〇2濃度下で培養した。 増殖期にある細胞を調製し、 4 X 1 04個 /m l となるように基本培地に懸濁した。 これを 24マルチウエル細胞 培養用プレート (ファルコン社製 3 0 4 6 ) に l m lずつ添加し、 コン ファレントになるまで培養した。 コンファレン卜に増殖した細胞の培地 を分化誘導培地 ( 2 % F B Sを含む D— MEM培地) に交換し、 分化を 誘導した。 その後、 48時間毎に分化誘導培地を用いて培地交換をおこ ない、 4 5 日後に多核筋管細胞を得た。 Using the myoblast L6 derived from rat skeletal muscle, the effect of promoting glucose uptake on the myocytes of B. agaricus was demonstrated. L6 cells used for the test were purchased from Dainippon Pharmaceutical Co., Ltd. L 6 cells were cultured at 3 7 ° C, 5% C_〇 2 concentration under using carbon dioxide gas incubator at basal medium (D-MEM medium containing 1 0% FBS). Cells in the growth phase were prepared and suspended in a basal medium at 4 × 10 4 cells / ml. This was added to a 24-multiwell cell culture plate (30464, manufactured by Falcon) in an amount of 1 ml each, and the cells were cultured until they became conferred. The medium of cells grown in the conference was replaced with a differentiation-inducing medium (D-MEM medium containing 2% FBS) to induce differentiation. Thereafter, the medium was replaced with a differentiation-inducing medium every 48 hours, and multinucleated myotube cells were obtained 45 days later.

ブナハリ夕ケ抽出物の調製は以下の通りに行った。 上記実施例 2記載 のブナハリタケ乾燥粉末 0. 2 5 にへキサン、 ジェチルェ一テル、 ァ セトン、 クロ口ホルム、 メタノール、 エタノール、 水をそれぞれ 1 0 m 1加え、 一晩振とうした。 熱水抽出は、 ブナハリタケ乾燥粉末 0. 2 5 gに水 1 0 m l を加えォートクレーブをもちいて 1 0 5 °C、 5分間加熱 した。 これら抽出液をろ紙でろ過し、 ろ液を減圧乾固して、 抽出物を得 た。 それぞれの収量を表 5に示す。 へキサン、 ジェチルエーテル、 ァセ トン、 クロロホルム、 メタノ一ル、 エタノール抽出物は、 ジメチルスル ホオキサイ ド (D I MS O) で、 水、 熱水抽出物は水で、 それぞれ 0. 1 /m 1 となるように溶解し、 抽出液とした。 The preparation of the Beechari Yuga extract was performed as follows. 0.25 of the dried powder of Beech agaricus described in Example 2 above was mixed with hexane, gethyruether, acetone, 10 ml of form, methanol, ethanol, and water respectively. Add 1 and shake overnight. For hot water extraction, 10 ml of water was added to 0.25 g of the dried powder of Bunakaritake, and the mixture was heated at 105 ° C for 5 minutes using an autoclave. These extracts were filtered with filter paper, and the filtrate was dried under reduced pressure to obtain an extract. Table 5 shows the yields. Hexane, getyl ether, acetone, chloroform, methanol, and ethanol extracts are dimethyl sulfoxide (DI MSO), and water and hot water extracts are water. And dissolved to obtain an extract.

表 5 Table 5

Figure imgf000018_0001
分化誘導して得られた多核筋管細胞の培地を、 新鮮な分化誘導培地に 交換した後、 1 1のブナハリタケ抽出液をそれぞれ培地に加え、 培養 した。 抽出液添加 48時間後に培地を取り出し、 培地中のグルコース量 を測定した。 培地中に残っているグルコース量を表 6に示す。 培地中に ブナハリタケ抽出物を添加していない無添加と比較して、 ジェチルェ一 テルとクロ口ホルム抽出液で、有意にグルコース量の低下が観察された。 従って、 ブナハリタケには筋組織においてグルコースの取り込みを増加 させ、 血糖値を低下させる可能性が示された。
Figure imgf000018_0001
After replacing the medium of the multinucleated myotube cells obtained by inducing differentiation with a fresh differentiation inducing medium, 11 B. agaricus extracts were added to each medium and cultured. The culture medium was removed 48 hours after the addition of the extract, and the amount of glucose in the culture medium was measured. Table 6 shows the amount of glucose remaining in the medium. Compared with the case where no Bunakaritake extract was added to the medium, a significant decrease in the amount of glucose was observed in the extract of Jetilether and in the extract of black-mouthed form. Thus, it was shown that B. agarita may increase glucose uptake in muscle tissue and lower blood glucose levels.

6 表 6 6 Table 6

Figure imgf000019_0001
Figure imgf000019_0001

*:危険率 5%で有意差あり 実施例 6 [脂肪細胞に対する効果]  *: Significant difference at 5% risk Example 6 [Effect on fat cells]

マウス脂肪組織由来の脂肪前駆細胞 3 T 3 L 1細胞:  Preadipocytes 3 T 3 L 1 cells derived from mouse adipose tissue:

リタケの脂肪細胞に対するグルコース取り込み促進効果を調べた。 試験 に使用する 3 T 3 L 1細胞は大日本製薬株式会社から購入した。 3 T 3 L 1細胞は、 基本培地 ( 1 0 % F B Sを含む D— MEM培地) で炭酸ガ スインキュベータをもちい 3 7 、 5 % C〇 2濃度下で培養した。 増殖 期にある細胞を調製し、 5 X 1 04個 Zm 1 となるように基本培地に懸 濁した。 これを 2 4マルチウエル細胞培養用プレートに 1 m 1毎に添加 し、 コンファレントになるまで培養した。 コンファレントに増殖した細 胞の培地を分化誘導培地 (基本培地に 0. 2 5 Mのデキサメタゾン、 0. 5 mMの 1—メチル— 3 _イソブチルキサンチン、 1 0 H g /m 1 のインスリンを含む培地) に交換し、 分化を誘導した。 4 8時間後に成 熟促進培地 (基本培地に 5 g/m 1 のインスリンを含む培地) に交換 し、 その後 4 8時間毎に成熟促進培地の交換をおこない、 4〜 5 日後に 成熟した脂肪細胞を得た。 The effect of mushrooms on promoting glucose uptake on fat cells was examined. 3T3L1 cells used in the test were purchased from Dainippon Pharmaceutical Co., Ltd. The 3T3L1 cells were cultured in a basal medium (D-MEM medium containing 10% FBS) under a 37,5% C% 2 concentration using a gas carbonate incubator. Cells in the growth phase were prepared and suspended in a basal medium to 5 × 10 4 Zm 1. This was added to a 24 multi-well cell culture plate every 1 ml, and cultured until it became a confident. The culture medium of the cells grown in the conferent cells is transformed into a differentiation-inducing medium (basic medium contains 0.25 M dexamethasone, 0.5 mM 1-methyl-3-isobutylxanthine, and 10 Hg / m1 insulin). Medium) to induce differentiation. 48 After 8 hours, replace the medium with a maturation promoting medium (medium containing 5 g / m1 of insulin in the basal medium), and then replace the maturation promoting medium every 48 hours. After 4 to 5 days, mature adipocytes I got

成熟した脂肪細胞の培地を、 新鮮な基本培地に交換した後、 実施例 5 で調製したブナハリタケ抽出液 1 I 1 をそれぞれ培地に加え、培養した。 抽出液添加 4 8時間後に培地を取り出し、 培地中のグルコース量を測定 した。 培地中に残っているダルコ一ス量を表 7に示す。 表 7からわかる ように、 培地中にブナハリタケ抽出物を添加していない無添加と比較し て、 へキサン、 ジェチルェ一テル、 アセトン、 クロ口ホルム、 メタノー ル抽出液で、 有意にグルコース量の低下が観察された。 従って、 ブナハ リタケには脂肪組織においてグルコースの取り込みを増加させ、 血糖値 を低下させる可能性が示された。 After the medium of the mature adipocytes was replaced with a fresh basal medium, the fungus mushroom extract 1 I 1 prepared in Example 5 was added to each medium and cultured. The culture medium was taken out 48 hours after the addition of the extract, and the amount of glucose in the medium was measured. Table 7 shows the amount of Darcos remaining in the medium. As can be seen from Table 7, the amount of glucose was significantly lower in the hexane, getyl ether, acetone, chloroform, and methanol extracts compared to the case without the addition of the Buna mushroom extract in the medium. Was observed. Therefore, it was shown that B. agarita may increase glucose uptake in adipose tissue and decrease blood glucose level.

表 7 Table 7

Figure imgf000020_0001
Figure imgf000020_0001

* :危険率 5¾で有意差あり 産業上の利用可能性  *: Significant difference with a risk factor of 5¾ Industrial applicability

本発明の糖尿病予防 ·改善剤や糖尿病予防 · 改善作用を有する機能性 食品は、 天然物であるキノコに由来し、 安全性が高く、 かつ 1型糖尿病 や 2型糖尿病に対する血糖値上昇抑制作用と耐糖能改善作用を有するの で、 本発明の抗腫瘍剤や腫瘍改善作用を有する機能性食品を摂取するこ とにより、 糖尿病の予防効果や糖尿病の治療効果が期待できる。 また、 子実体としてブナ八リタケの人工栽培物を原料として利用することによ り、 安価かつ品質の安定した糖尿病予防 ·改善剤を周年安定的に製造す ることができる。  The functional food having the diabetes preventive and ameliorating agent and the diabetes preventive and ameliorating effect of the present invention is derived from a natural product, mushroom, and is highly safe, and has a blood sugar level suppressing effect on type 1 diabetes and type 2 diabetes. Since it has a glucose tolerance improving effect, ingestion of the antitumor agent of the present invention or a functional food having a tumor improving effect can be expected to have a preventive effect on diabetes and a therapeutic effect on diabetes. In addition, by using an artificially cultivated product of Buna hachitake as a fruiting body, it is possible to manufacture an inexpensive and stable agent for preventing and ameliorating diabetes mellitus with stable quality throughout the year.

Claims

請 求 の 範 囲 The scope of the claims 1 . ェゾハリ夕ケ科 (Climacodontaceae) のキノコの子実体又はその処 理物を有効成分とする糖尿病予防 ·改善剤。 1. An antidiabetic agent comprising a mushroom fruit body of Climacodontaceae or a processed product thereof as an active ingredient. 2 . ェゾハリタケ科 (Climacodontaceae) のキノコが、 ブナハリ夕ケ属 (Mycoleptodonoides) のキノコである請求項 1記載の糖尿病予防 ·改 善剤。 2. The diabetes preventive and ameliorating agent according to claim 1, wherein the mushroom of the family Climacodontaceae is a mushroom of the genus Mycoleptodonoides. 3 . ブナハリタケ属 (Mycoleptodonoides) のキノコが、 ブナハリタケ (Mycoleptodonoides aitchisonii) である請求項 2記載の糖尿病予防 · 改善剤。  3. The preventive and ameliorating agent for diabetes according to claim 2, wherein the mushroom of the genus Mycoeptodonoides is Mycoeptodonoides aitchisonii. 4 . 処理物が乾燥粉体である請求項 1〜 3のいずれか記載の糖尿病予 防 ·改善剤。  4. The diabetes prevention / improvement agent according to any one of claims 1 to 3, wherein the processed product is a dry powder. 5 . 処理物が溶媒抽出物である請求項 1〜 3のいずれか記載の糖尿病予 防 ·改善剤。  5. The diabetes prevention / improvement agent according to any one of claims 1 to 3, wherein the processed product is a solvent extract. 6 . ブナハリタケ子実体が人工栽培で得られたブナハリタケ子実体であ ることを特徴とする請求項 3〜 5のいずれか記載の糖尿病予防'改善剤。6. The preventive or ameliorating agent for diabetes according to any one of claims 3 to 5, wherein the fruit body of the fungus is a fruit body of a fungus obtained by artificial cultivation. 7 . 人工栽培が菌床栽培であることを特徴とする請求項 6記載の糖尿病 予防 ·改善剤。 7. The preventive and ameliorating agent for diabetes according to claim 6, wherein the artificial cultivation is a fungal bed cultivation. 8 . 菌床栽培が、 保水体と乾燥おから及びビール粕のうち少なくとも一 方を含む栽培用栄養源と水とを混合した培地を滅菌する滅菌工程と、 滅 菌した培地にブナハリタケの種菌を接種する接種工程と、 ブナハリタケ の種菌が接種された培地を培養し、 培地に菌糸が生育した菌床を得る前 培養工程と、 該菌床を培養し、 子実体に成長しうる物理的空間に曝され ていないブナハリタケ原基を得る中培養工程と、 該子実体に成長しうる 物理的空間に曝されていないブナハリタケ原基の中から選ばれた原基を, ブナハリタケ原基が子実体に成長しうる物理的空間に曝される条件下で 培養し、 ブナハリタケ子実体を得る後培養工程からなることを特徴とす る請求項 7記載の糖尿病予防 ·改善剤。 8. Bacterial bed cultivation is a sterilization step of sterilizing a medium in which water is mixed with a cultivation nutrient including at least one of a water retention body, dried okara and beer lees, and a seed culture of B. aeruginosa on the sterilized medium. An inoculation step of inoculation, a pre-culturing step of culturing a medium inoculated with a Bacillus inoculum inoculum and obtaining a bacterial bed on which the mycelia have grown, and a physical space in which the bacterial bed is cultured and can grow into fruiting bodies. A medium culturing step for obtaining unexposed B. agaricus primordium, and a primordia selected from among the unexposed B. agaricus primordia that have not been exposed to a physical space that can grow into the fruiting body. Under the conditions exposed to the physical space 8. The preventive and ameliorating agent for diabetes according to claim 7, which comprises a post-culturing step of culturing to obtain a fruit body of B. aeruginosa. 9 , ブナハリタケ子実体が、 ブナハリ夕ケ (F E RM B P— 6 6 9 7 ) の子実体であることを特徴とする請求項 3〜 8のいずれか記載の糖尿病 予防 ·改善剤。  9. The preventive and ameliorating agent for diabetes according to any one of claims 3 to 8, wherein the fruiting body of Bunakaritake is a fruiting body of Bunakariyuke (FERMBP-66697). 1 0. 請求項 1〜 9のいずれか記載の糖尿病予防 ·改善剤を含んでなる 糖尿病予防 ·改善作用を有する機能性食品。  10. A functional food having a diabetes prevention / ameliorating action, comprising the diabetes prevention / ameliorating agent according to any one of claims 1 to 9.
PCT/JP2001/011090 2000-12-19 2001-12-18 Preventievs/remedies for diabetes and functional foods containing the same Ceased WO2002049661A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000-386092 2000-12-19
JP2000386092A JP2002187851A (en) 2000-12-19 2000-12-19 Diabetes prevention / amelioration agent and functional food containing it

Publications (1)

Publication Number Publication Date
WO2002049661A1 true WO2002049661A1 (en) 2002-06-27

Family

ID=18853243

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2001/011090 Ceased WO2002049661A1 (en) 2000-12-19 2001-12-18 Preventievs/remedies for diabetes and functional foods containing the same

Country Status (2)

Country Link
JP (1) JP2002187851A (en)
WO (1) WO2002049661A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4602674B2 (en) * 2004-01-30 2010-12-22 野田食菌工業株式会社 Maltase inhibitor
KR100809375B1 (en) * 2006-04-03 2008-03-05 조선대학교산학협력단 Health functional foods including sesame needles and aloe
JP2008178363A (en) * 2007-01-25 2008-08-07 Tohoku Univ Leptin signaling model animal
KR101267886B1 (en) * 2010-06-30 2013-05-27 전라남도 composition using Mycoleptodonoides aitchisonii for preventing and treating dyslipidemia in diabetes
JP2013059332A (en) * 2012-10-26 2013-04-04 Tohoku Univ Method for analyzing sensitivity of obesity or diabetes onset to social isolation during growing stage of mouse

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09124541A (en) * 1995-10-27 1997-05-13 Kagome Co Ltd New compound and nerve growth factor productive inducer with the same as active ingredient

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63157947A (en) * 1986-12-19 1988-06-30 Mori Sangyo Kk Preparation of noodle

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09124541A (en) * 1995-10-27 1997-05-13 Kagome Co Ltd New compound and nerve growth factor productive inducer with the same as active ingredient

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
HIROSHI YOSHIDA ET AL.: "The chemical component in the vegetative mycelia of basidiomycotina", NIPPON KINGAKUKAI KAIHO, vol. 37, no. 2, 1996, pages 51 - 56, XP002909374 *
KEN YASUKAWA ET AL.: "Inhibitory effect of methanol extracts from edible mushroom on TPA-induced ear oedema and tumor promotion in mouse skin", PHOTOTHERAPY RESEARCH, vol. 10, no. 4, 1996, pages 367 - 369, XP002909376 *
YOSHIMASA KASAHARA ET AL.: "Effect of methanol extract fruit body of mycoleptodonoides aitchisonii on acute and chronic inflammation models", J. FOOD HYGIENIC SOCIETY OF JAPAN, vol. 40, no. 5, 1999, pages 368 - 374, XP002909375 *

Also Published As

Publication number Publication date
JP2002187851A (en) 2002-07-05

Similar Documents

Publication Publication Date Title
KR101959986B1 (en) Composition of comprising vegetable worms extract cultured using mealworm or pupa and process of fabrication the extract
KR102254420B1 (en) Antimicrobial composition comprising the fermentation extract of medicinal or edible natural products
WO2006016701A1 (en) Agent for preventing/ameliorating diabetes and functional food for preventing/ameliorating diabetes
KR101400021B1 (en) The method for cultivation various mushrooms using natural substances
KR101598395B1 (en) Method for producing wild plants Kimchi comprising Houttuynia cordata, Saururus chinensis and Momordica charantia
KR101908392B1 (en) Manufacturing method of alcoholic beverage fermented by mushroom
KR102514930B1 (en) Manufacturing method for growing mushroom medium using corn stalk and by-product of sugar cane stalk
JP5144112B2 (en) Brain protectant
KR102066637B1 (en) Composition for Inhibiting Proliferation of Helicobacter Pylori Comprising Complex Plant Extracts and Uses Thereof
JP2008255057A (en) Anticancer agent, method for producing anticancer agent, and food and drink
WO2002049661A1 (en) Preventievs/remedies for diabetes and functional foods containing the same
JP3618653B2 (en) Pharmacological composition having blood pressure lowering effect
JP2003169621A (en) Tea of momordica charantia and method for producing the same
KR101326274B1 (en) Feed additives for eel and manufacturing method thereof and culturing method of eel using the same
KR100977076B1 (en) Anti-Helicobacter Composition Containing Schisandra chinensis Extract and Bokbunja Extract
JP2020005539A (en) Culture medium, method for obtaining useful substance, useful substance and use therefor
KR102087041B1 (en) Manufacturing method of health food composition for diet
KR101962893B1 (en) Composition of comprising vegetable worms extract cultured using mealworm or pupa and process of fabrication the extract
KR101416174B1 (en) Grape vinegar having an anti-cancer effect and the method for preparing the same
JP2002187850A (en) Antitumor agent and functional food containing it
KR102281855B1 (en) Method for Manufacturing Spirulina sp. Algae using minimal medium
KR102621081B1 (en) Method for manufacturing seasoning sauce for shellfish and seafood
JPH10120589A (en) Antibacterial agent and antibacterial food
KR20150019739A (en) Functional food composition for side effects relief after anticancer therapy
KR20130011016A (en) Media composition containing soy, fermented soy product, and composition for weight control containing the same

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
122 Ep: pct application non-entry in european phase